These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2239475)

  • 1. Risk factors for dementia in Parkinson's disease.
    Salganik I; Korczyn A
    Adv Neurol; 1990; 53():343-7. PubMed ID: 2239475
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease.
    Haugarvoll K; Aarsland D; Wentzel-Larsen T; Larsen JP
    Acta Neurol Scand; 2005 Dec; 112(6):386-90. PubMed ID: 16281921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study.
    Kurz MW; Larsen JP; Kvaloy JT; Aarsland D
    Mov Disord; 2006 Dec; 21(12):2170-4. PubMed ID: 17029273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled study of dementia in Parkinson's disease over 54 months.
    Mindham RH; Biggins CA; Boyd JL; Harrop FM; Madeley P; Randall JI; Spokes EG
    Adv Neurol; 1993; 60():470-4. PubMed ID: 8420172
    [No Abstract]   [Full Text] [Related]  

  • 5. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy.
    De Michele G; Filla A; Volpe G; De Marco V; Gogliettino A; Ambrosio G; Marconi R; Castellano AE; Campanella G
    Mov Disord; 1996 Jan; 11(1):17-23. PubMed ID: 8771062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Hely MA; Morris JG; Reid WG; Trafficante R
    Mov Disord; 2005 Feb; 20(2):190-9. PubMed ID: 15551331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of risk factors for dementia in Parkinson's disease.
    Marder K; Flood P; Cote L; Mayeux R
    Mov Disord; 1990; 5(2):156-61. PubMed ID: 2325678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
    Olsson JE
    Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 12. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
    Montastruc JL; Fabre N; Blin O; Senard JM; Rascol O; Rascol A
    Mov Disord; 1995 May; 10(3):355-7. PubMed ID: 7651460
    [No Abstract]   [Full Text] [Related]  

  • 13. Vitamin E therapy in Parkinson's disease.
    Factor SA; Sanchez-Ramos JR; Weiner WJ
    Adv Neurol; 1990; 53():457-61. PubMed ID: 2239484
    [No Abstract]   [Full Text] [Related]  

  • 14. Young onset Parkinson's disease.
    Quinn N; Critchley P; Marsden CD
    Mov Disord; 1987; 2(2):73-91. PubMed ID: 3504266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease in 1984: an update.
    Lang AE; Blair RD
    Can Med Assoc J; 1984 Nov; 131(9):1031-7. PubMed ID: 6388779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Madopar HBS (hydrodynamically balanced system) in the treatment of Parkinson's disease.
    Lees AJ
    Adv Neurol; 1990; 53():475-82. PubMed ID: 2239487
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuropathology of dementia in Parkinson's disease.
    Jellinger KA
    Ann Neurol; 2006 Apr; 59(4):727. PubMed ID: 16566020
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease.
    Devos D;
    Mov Disord; 2009 May; 24(7):993-1000. PubMed ID: 19253412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-dopa and frontal cognitive function in Parkinson's disease.
    Lange KW; Paul GM; Robbins TW; Marsden CD
    Adv Neurol; 1993; 60():475-8. PubMed ID: 8420173
    [No Abstract]   [Full Text] [Related]  

  • 20. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Giménez-Roldán S; Mateo D; Dobato JL
    Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.